IperionX Limited American Depositary Share
$ 45.28
4.77%
24 Feb - close price
- Market Cap 1,453,587,000 USD
- Current Price $ 45.28
- High / Low $ 45.74 / 42.28
- Stock P/E N/A
- Book Value 0.29
- EPS -1.18
- Next Earning Report 2026-03-17
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.31 %
- ROE -0.49 %
- 52 Week High 61.45
- 52 Week Low 12.28
About
IperionX Limited is engaged in the exploration and development of mineral properties. The company is headquartered in Charlotte, North Carolina.
Analyst Target Price
$67.75
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-12-03 | 2025-09-30 | 2025-05-28 | 2025-03-12 | 2024-11-27 | 2024-09-26 | 2023-09-29 | 2023-05-31 | 2023-03-14 | 2022-11-30 |
| Reported EPS | 0 | -0.06 | 0 | -0.06 | 0 | -0.05 | 0 | 0 | -0.15 | -0.21 |
| Estimated EPS | 0 | -0.04 | 0 | -0.085 | 0 | 0 | -0.21 | 0 | -0.15 | 0 |
| Surprise | 0 | -0.02 | 0 | 0.025 | 0 | -0.05 | 0.21 | 0 | 0 | -0.21 |
| Surprise Percentage | None% | -50% | None% | 29.4118% | None% | None% | 100% | None% | 0% | None% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-17 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.3 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: IPX
2026-02-24 00:33:54
IperionX Limited has issued 1,288,179 new fully paid ordinary shares on the ASX under an Australian disclosure exemption. The company confirmed that the issuance adheres to Australian corporations law, requiring no prospectus, and complies with its financial reporting and continuous disclosure obligations without any undisclosed information. This move expands IperionX’s equity base to support capital needs while maintaining transparency and regulatory adherence.
2026-02-23 23:33:54
IperionX Limited (ASX:IPX, NASDAQ:IPX) announced it is issuing 1,273,179 ordinary shares at $4.11 each to settle a cashless obligation, thereby preserving its cash reserves. This move, which slightly dilutes existing shareholders, offers equity access for investors in both Australian and U.S. markets. The settlement is expected around February 24, 2026, and the shares will be issued directly by the company.
2026-02-11 03:28:41
An Independent Non-Executive Director at IperionX (ASX:IPX), Vaughn Taylor, recently sold AU$1.0m worth of shares. While this reduced his holding by 13%, the company has seen more insider buying than selling over the past year, with insiders purchasing AU$3.0m worth of shares compared to AU$2.0m in sales. Insiders still own a significant 17% of the company, indicating strong alignment with shareholder interests despite the recent sale.
2026-02-10 05:28:47
An Independent Non-Executive Director at IperionX Limited recently sold AU$1.0m worth of shares, reducing their holding by 13%. While this is a substantial sale, insider ownership remains considerable at 17%. Over the last year, there has been more insider buying than selling, although major purchases were made at prices below the current share price.
2026-02-09 06:58:48
IperionX Director Vaughn Taylor sold 150,000 shares for A$1,025,351 to meet tax obligations. This on-market sale, conducted by a related entity, reduces Taylor's indirect holding to 973,457 shares while his 84,771 restricted stock units remain unchanged. The transaction is viewed as a routine personal portfolio adjustment for tax purposes and does not indicate a shift in the company's strategic direction.
2026-02-05 03:29:13
IperionX (ASX:IPX) recently secured a US$0.3 million prototype order for lightweight titanium components for U.S. Army ground combat systems, following significant share price growth over the past year. While its Price-to-Book ratio of 17.4x suggests overvaluation compared to peers, a Discounted Cash Flow (DCF) model indicates the shares might be trading at a substantial discount to their estimated fair value. The company, however, remains unprofitable with no reported revenue, presenting risks despite its future potential.
